Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3

  • Authors:
    • Minhao Wu
    • Aiqin Cao
    • Bin Dong
    • Jingwen Liu
  • View Affiliations

  • Published online on: February 23, 2011     https://doi.org/10.3892/ijmm.2011.624
  • Pages: 655-662
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

ACSL3 is a member of the long chain acyl-CoA synthetase (ACSL) family that consists of 5 isozymes responsible for cellular fatty acid metabolism in various tissues in an isozyme-specific manner. Our previous studies have demonstrated that expression of ACSL3 mRNA and protein in liver was specifically increased after feeding hamsters with a fat- and cholesterol-enriched diet, providing the first in vivo evidence for the regulated expression of ACSL3 in liver tissue. The aim of the current study was to further investigate the role of ACSL3 in regulating hepatic lipid metabolism in vitro and in vivo. We utilized an adenoviral-mediated gene delivery approach to exogenously express hamster ACSL3 in hamster liver as well as in HepG2 cells. Transduction of HepG2 cells with Ad-hamACSL3 adenovirus elevated total cellular ACSL enzyme activity, which was accompanied by a significant reduction of cellular contents of triglycerides and total phospholipids. Immunostaining and confocal microscopy studies revealed that ACSL3 was localized to endoplasmic reticulum and mitochondria. In vivo, infection of hamsters with Ad-hamACSL3 led to sustained expression of ACSL3 mRNA and protein in liver two weeks after infection. Importantly, compared with Ad-GFP control virus infected hamsters, we observed significantly lower free fatty acids and triglycerides plus modest reduction of phospholipids in the serum of Ad-hamACSL3 infected animals. Furthermore, triglyceride levels were significantly reduced in Ad-hamACSL3 infected hamster liver. Altogether, these results provide important and physiologically relevant evidence that strengthens the link between ACSL3 expression and hepatic reduction of triglycerides and fatty acids.

Related Articles

Journal Cover

May 2011
Volume 27 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu M, Cao A, Dong B and Liu J: Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3. Int J Mol Med 27: 655-662, 2011
APA
Wu, M., Cao, A., Dong, B., & Liu, J. (2011). Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3. International Journal of Molecular Medicine, 27, 655-662. https://doi.org/10.3892/ijmm.2011.624
MLA
Wu, M., Cao, A., Dong, B., Liu, J."Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3". International Journal of Molecular Medicine 27.5 (2011): 655-662.
Chicago
Wu, M., Cao, A., Dong, B., Liu, J."Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3". International Journal of Molecular Medicine 27, no. 5 (2011): 655-662. https://doi.org/10.3892/ijmm.2011.624